Seven Eight Capital’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Seven Eight Capital’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-29,300	Closed	-$2.91M	–	764
2018 Q2	$2.91M	Buy	+29,300	New	+$2.53M	0.2%	154
2016 Q4	–	Sell	-3,100	Closed	-$386K	–	681
2016 Q3	$386K	Buy	3,100 +2,200	+244%	+$260K	0.11%	233
2016 Q2	$96K	Buy	+900	New	+$105K	0.03%	404
2015 Q4	–	Sell	-400	Closed	-$36K	–	760
2015 Q3	$36K	Buy	+400	New	+$42.2K	0.03%	370

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Seven Eight Capital's CBPO Position: Q3 2018 in Review

Seven Eight Capital sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2018, closing a stake of 29,300 shares — an estimated $2.91M sold.

Seven Eight Capital first reported a position in CBPO in Q3 2015 and held it in 4 quarters. The position peaked at $2.91M in Q2 2018. 82 funds tracked by Wall St. Rank hold CBPO as of Q3 2018.

Seven Eight Capital reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2018 after selling out during the quarter.
Seven Eight Capital sold 29,300 China Biologic Products Holdings, Inc. shares in Q3 2018, an estimated $2.91M.
Seven Eight Capital first reported a position in China Biologic Products Holdings, Inc. in Q3 2015 and held it in 4 quarters.
Seven Eight Capital's China Biologic Products Holdings, Inc. position peaked at $2.91M in Q2 2018.
82 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2018.

Based on Seven Eight Capital's 13F filing for Q3 2018, filed 18 Oct 2018.